You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽諾醫療(688108.SH):上半年淨利潤同比預增296.54%

格隆匯7月24日丨賽諾醫療(688108.SH)公佈2025年半年度業績預告,財務部門初步測算,預計本報告期營業收入爲2.4億元,同比增長12.53%。報告期內,預計實現歸屬於上市公司股東的淨利潤爲1,384萬元,同比增長296.54%。報告期內,預計實現歸屬於上市公司股東的扣除非經常性損益後的淨利潤爲798萬元,同比增長163.35%。

2025年上半年度,公司業績較上年同期增長主要系公司進入集採範圍的兩款冠脈支架產品以及冠脈球囊產品銷量大幅增長,且神經介入業務保持穩中有升,營業成本同比小幅增長,銷售費用和研發費用同比下降,併疊加管理費用同比增長、以及投資收益和資產減值損失同比大幅下降等因素綜合影響所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account